Dolby Laboratories (DLB) - Net Assets
Based on the latest financial reports, Dolby Laboratories (DLB) has net assets worth $2.60 Billion USD as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.20 Billion) and total liabilities ($591.27 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Dolby Laboratories asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $2.60 Billion |
| % of Total Assets | 81.5% |
| Annual Growth Rate | 16.01% |
| 5-Year Change | 1.99% |
| 10-Year Change | 37.1% |
| Growth Volatility | 42.3 |
Dolby Laboratories - Net Assets Trend (2003–2024)
This chart illustrates how Dolby Laboratories's net assets have evolved over time, based on quarterly financial data. Also explore Dolby Laboratories (DLB) total assets for the complete picture of this company's asset base.
Annual Net Assets for Dolby Laboratories (2003–2024)
The table below shows the annual net assets of Dolby Laboratories from 2003 to 2024. For live valuation and market cap data, see Dolby Laboratories stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-09-30 | $2.49 Billion | +4.84% |
| 2023-09-30 | $2.37 Billion | +5.38% |
| 2022-09-30 | $2.25 Billion | -13.56% |
| 2021-09-30 | $2.60 Billion | +6.80% |
| 2020-09-30 | $2.44 Billion | +5.42% |
| 2019-09-30 | $2.31 Billion | +5.32% |
| 2018-09-30 | $2.20 Billion | +2.44% |
| 2017-09-30 | $2.14 Billion | +8.34% |
| 2016-09-30 | $1.98 Billion | +9.08% |
| 2015-09-30 | $1.81 Billion | +4.75% |
| 2014-09-30 | $1.73 Billion | +15.44% |
| 2013-09-30 | $1.50 Billion | -13.95% |
| 2012-09-30 | $1.74 Billion | +3.43% |
| 2011-09-30 | $1.69 Billion | +12.76% |
| 2010-09-30 | $1.49 Billion | +9.65% |
| 2009-09-30 | $1.36 Billion | +27.23% |
| 2008-09-30 | $1.07 Billion | +30.74% |
| 2007-09-30 | $819.43 Million | +33.42% |
| 2006-09-30 | $614.20 Million | +28.12% |
| 2005-09-30 | $479.40 Million | +198.64% |
| 2004-09-30 | $160.53 Million | +46.06% |
| 2003-09-30 | $109.91 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Dolby Laboratories's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 249625500000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $2.50 Billion | 100.77% |
| Common Stock | $94.00K | 0.00% |
| Other Comprehensive Income | $-19.19 Million | -0.77% |
| Total Equity | $2.48 Billion | 100.00% |
Dolby Laboratories Competitors by Market Cap
The table below lists competitors of Dolby Laboratories ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
AUTO1 Group SE
F:AG1
|
$3.52 Billion |
|
GQG Partners Inc
AU:GQG
|
$3.52 Billion |
|
Beijing Teamsun Technology Co Ltd
SHG:600410
|
$3.52 Billion |
|
Sacyr SA
MC:SCYR
|
$3.52 Billion |
|
Xi an Bright Laser Tech Co Ltd
SHG:688333
|
$3.52 Billion |
|
INDIVIOR PLC DL 050
F:2IVB
|
$3.51 Billion |
|
Amcor plc
F:485
|
$3.51 Billion |
|
Jiangsu Phoenix Publishing & Media Corp Ltd
SHG:601928
|
$3.51 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dolby Laboratories's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,355,100,000 to 2,477,162,000, a change of 122,062,000 (5.2%).
- Net income of 360,642,000 contributed positively to equity growth.
- Dividend payments of 114,579,000 reduced retained earnings.
- Share repurchases of 199,076,000 reduced equity.
- New share issuances of 40,203,000 increased equity.
- Other comprehensive income increased equity by 17,797,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $360.64 Million | +14.56% |
| Dividends Paid | $114.58 Million | -4.63% |
| Share Repurchases | $199.08 Million | -8.04% |
| Share Issuances | $40.20 Million | +1.62% |
| Other Comprehensive Income | $17.80 Million | +0.72% |
| Other Changes | $17.07 Million | +0.69% |
| Total Change | $- | 5.18% |
Book Value vs Market Value Analysis
This analysis compares Dolby Laboratories's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.26x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 80.54x to 2.26x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-09-30 | $0.71 | $57.46 | x |
| 2003-09-30 | $1.09 | $57.46 | x |
| 2004-09-30 | $1.54 | $57.46 | x |
| 2005-09-30 | $4.42 | $57.46 | x |
| 2006-09-30 | $5.32 | $57.46 | x |
| 2007-09-30 | $7.02 | $57.46 | x |
| 2008-09-30 | $9.14 | $57.46 | x |
| 2009-09-30 | $11.62 | $57.46 | x |
| 2010-09-30 | $12.95 | $57.46 | x |
| 2011-09-30 | $14.78 | $57.46 | x |
| 2012-09-30 | $16.00 | $57.46 | x |
| 2013-09-30 | $14.41 | $57.46 | x |
| 2014-09-30 | $16.50 | $57.46 | x |
| 2015-09-30 | $17.38 | $57.46 | x |
| 2016-09-30 | $19.24 | $57.46 | x |
| 2017-09-30 | $20.69 | $57.46 | x |
| 2018-09-30 | $20.47 | $57.46 | x |
| 2019-09-30 | $22.06 | $57.46 | x |
| 2020-09-30 | $23.63 | $57.46 | x |
| 2021-09-30 | $24.83 | $57.46 | x |
| 2022-09-30 | $22.03 | $57.46 | x |
| 2023-09-30 | $24.13 | $57.46 | x |
| 2024-09-30 | $25.45 | $57.46 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Dolby Laboratories utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.56%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 28.31%
- • Asset Turnover: 0.41x
- • Equity Multiplier: 1.26x
- Recent ROE (14.56%) is above the historical average (14.22%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | 9.32% | 4.53% | 0.99x | 2.07x | $-413.50K |
| 2003 | 33.02% | 14.24% | 1.07x | 2.16x | $21.59 Million |
| 2004 | 27.80% | 13.78% | 1.10x | 1.83x | $25.51 Million |
| 2005 | 11.34% | 15.94% | 0.56x | 1.27x | $6.18 Million |
| 2006 | 15.07% | 22.87% | 0.53x | 1.24x | $30.12 Million |
| 2007 | 17.92% | 29.63% | 0.49x | 1.24x | $63.12 Million |
| 2008 | 19.01% | 31.15% | 0.48x | 1.27x | $94.53 Million |
| 2009 | 18.12% | 33.77% | 0.46x | 1.18x | $108.88 Million |
| 2010 | 18.96% | 30.72% | 0.54x | 1.15x | $133.98 Million |
| 2011 | 18.59% | 32.37% | 0.51x | 1.13x | $142.92 Million |
| 2012 | 15.36% | 28.53% | 0.47x | 1.14x | $92.28 Million |
| 2013 | 12.78% | 20.81% | 0.52x | 1.17x | $41.16 Million |
| 2014 | 12.05% | 21.47% | 0.48x | 1.16x | $35.10 Million |
| 2015 | 9.94% | 18.54% | 0.45x | 1.18x | $-1.17 Million |
| 2016 | 9.43% | 18.12% | 0.44x | 1.17x | $-11.17 Million |
| 2017 | 9.44% | 18.66% | 0.43x | 1.19x | $-11.87 Million |
| 2018 | 5.58% | 10.43% | 0.44x | 1.21x | $-96.71 Million |
| 2019 | 11.06% | 20.55% | 0.44x | 1.22x | $24.42 Million |
| 2020 | 9.51% | 19.91% | 0.40x | 1.20x | $-11.90 Million |
| 2021 | 11.94% | 24.21% | 0.41x | 1.20x | $50.43 Million |
| 2022 | 8.20% | 14.68% | 0.47x | 1.20x | $-40.53 Million |
| 2023 | 8.13% | 18.97% | 0.34x | 1.27x | $-44.04 Million |
| 2024 | 14.56% | 28.31% | 0.41x | 1.26x | $112.93 Million |
Industry Comparison
This section compares Dolby Laboratories's net assets metrics with peer companies in the Specialty Business Services industry.
Industry Context
- Industry: Specialty Business Services
- Average net assets among peers: $541,411,172
- Average return on equity (ROE) among peers: -0.49%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dolby Laboratories (DLB) | $2.60 Billion | 9.32% | 0.23x | $3.52 Billion |
| ABM Industries Incorporated (ABM) | $61.90 Million | 11.47% | 1.78x | $2.47 Billion |
| Amentum Holdings Inc. (AMTM) | $415.22 Million | -75.55% | 14.44x | $6.26 Billion |
| Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | $2.55 Million | 32.19% | 1.48x | $81.25 Million |
| Aramark Holdings (ARMK) | $3.72 Billion | 18.12% | 3.53x | $10.51 Billion |
| AZZ Incorporated (AZZ) | $375.91 Million | 15.85% | 1.54x | $4.12 Billion |
| Blacksky Technology Inc (BKSY) | $93.16 Million | -57.81% | 1.41x | $1.21 Billion |
| BUUU Group Limited Class A Ordinary Share (BUUU) | $1.34 Million | 62.16% | 0.93x | $210.15 Million |
| BrightView Holdings (BV) | $206.46 Million | -30.59% | 0.59x | $1.11 Billion |
| Cass Information Systems Inc (CASS) | $56.60 Million | 10.95% | 7.85x | $610.56 Million |
| CBIZ Inc (CBZ) | $480.02 Million | 8.35% | 1.33x | $1.52 Billion |
About Dolby Laboratories
Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions primarily for application in the television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec soluti… Read more